Clinical practice of sepsis-induced immunosuppression: Current immunotherapy and future options

Chin J Traumatol. 2023 Nov 8:S1008-1275(23)00114-1. doi: 10.1016/j.cjtee.2023.11.001. Online ahead of print.ABSTRACTSepsis is a potentially fatal condition characterized by the failure of one or more organs due to a disordered host response to infection. The development of sepsis is closely linked to immune dysfunction. As a result, immunotherapy has gained traction as a promising approach to sepsis treatment, as it holds the potential to reverse immunosuppression and restore immune balance, thereby improving the prognosis of septic patients. However, due to the highly heterogeneous nature of sepsis, it is crucial to carefully select the appropriate patient population for immunotherapy. This review summarizes the current and evolved treatments for sepsis-induced immunosuppression to enhance clinicians' understanding and practical application of immunotherapy in the management of sepsis.PMID:38040590 | DOI:10.1016/j.cjtee.2023.11.001
Source: Chinese Journal of Traumatology - Category: Orthopaedics Authors: Source Type: research